Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first541 to 560 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| FGFR2 fibroblast growth factor receptor 2 | 2263 HGNC:3689 | 1 | 224 | 28 | 609 | 5,646 | 13,465 |
| C5AR1 complement C5a receptor 1 | 728 HGNC:1338 | 1 | 31 | 2 | 19 | 5,123 | 13,454 |
| CAMP cathelicidin antimicrobial peptide | 820 HGNC:1472 | 1 | 74 | 0 | 0 | 6,159 | 13,428 |
| TGFB2 transforming growth factor beta 2 | 7042 HGNC:11768 | 1 | 247 | 5 | 117 | 6,475 | 13,404 |
| H19 H19 imprinted maternally expressed transcript | 283120 HGNC:4713 | 0 | 0 | 0 | 0 | 3,820 | 13,403 |
| SQSTM1 sequestosome 1 | 8878 HGNC:11280 | 1 | 91 | 0 | 0 | 5,398 | 13,305 |
| AQP4 aquaporin 4 | 361 HGNC:637 | 1 | 121 | 0 | 0 | 3,300 | 13,298 |
| PRNP prion protein (Kanno blood group) | 5621 HGNC:9449 | 2 | 292 | 0 | 0 | 3,897 | 13,239 |
| CGB5 chorionic gonadotropin subunit beta 5 | 93659 HGNC:16452 | 1 | 201 | 0 | 0 | 2,022 | 13,238 |
| CDH5 cadherin 5 | 1003 HGNC:1764 | 1 | 40 | 0 | 0 | 7,173 | 13,208 |
| ABCB6 ATP binding cassette subfamily B member 6 (LAN blood group) | 10058 HGNC:47 | 1 | 27 | 0 | 0 | 6,122 | 13,188 |
| THBD thrombomodulin | 7056 HGNC:11784 | 1 | 72 | 0 | 0 | 4,627 | 13,152 |
| ATF4 activating transcription factor 4 | 468 HGNC:786 | 1 | 65 | 0 | 0 | 6,531 | 13,145 |
| TGFBR1 transforming growth factor beta receptor 1 | 7046 HGNC:11772 | 1 | 199 | 2 | 42 | 6,549 | 13,131 |
| AGO2 argonaute RISC catalytic component 2 | 27161 HGNC:3263 | 1 | 33 | 0 | 0 | 4,703 | 13,119 |
| ERG ETS transcription factor ERG | 2078 HGNC:3446 | 1 | 67 | 0 | 0 | 5,328 | 13,102 |
| IKBKB inhibitor of nuclear factor kappa B kinase subunit beta | 3551 HGNC:5960 | 1 | 94 | 7 | 28 | 6,944 | 13,054 |
| ATG5 autophagy related 5 | 9474 HGNC:589 | 1 | 51 | 0 | 0 | 4,772 | 13,043 |
| PRKDC protein kinase, DNA-activated, catalytic subunit | 5591 HGNC:9413 | 1 | 55 | 1 | 3 | 6,463 | 13,016 |
| EPAS1 endothelial PAS domain protein 1 | 2034 HGNC:3374 | 1 | 46 | 1 | 30 | 5,377 | 12,992 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=28
{
"data": {
"total": 193990,
"results": [
{
"id": "2263",
"title": "FGFR2: fibroblast growth factor receptor 2",
"summary": "NCBI Gene 2263. 1 protein, 224 patents, 28 drugs, 609 trials, 5,646 NIH grants and 13,465 papers.",
"record": "/library/genes/2263",
"gene_id": 2263,
"symbol": "FGFR2",
"name": "fibroblast growth factor receptor 2",
"hgnc_id": "HGNC:3689",
"counts": {
"proteins": 1,
"patents": 224,
"drugs": 28,
"trials": 609,
"grants": 5646,
"papers": 13465
}
},
{
"id": "728",
"title": "C5AR1: complement C5a receptor 1",
"summary": "NCBI Gene 728. 1 protein, 31 patents, 2 drugs, 19 trials, 5,123 NIH grants and 13,454 papers.",
"record": "/library/genes/728",
"gene_id": 728,
"symbol": "C5AR1",
"name": "complement C5a receptor 1",
"hgnc_id": "HGNC:1338",
"counts": {
"proteins": 1,
"patents": 31,
"drugs": 2,
"trials": 19,
"grants": 5123,
"papers": 13454
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=29",
"request_id": "TrOCFbawHhuf0Gir"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant